Long-Term Efficacy and Safety of Benzoyl Peroxide Cream, 5%, Prepared with Microencapsulation in Papulopustular Rosacea: Results from an Extension of Two Phase 3, Vehicle-Controlled Trials

N Bhatia; W Werschler; H Baldwin; J Sugarman; L Stein Gold; L Green; E Lain

doi:10.25251/skin.5.supp.25

N Bhatia

Therapeutics Research Inc, San Diego, CA

W Werschler

Spokane Dermatology Clinic and Werschler Aesthetics, Spokane, WA

H Baldwin

Acne Treatment & Research Center, Brooklyn, NY

J Sugarman

University of California -San Francisco, San Francisco, CA

L Stein Gold

Henry Ford Health Systems, Detroit, MI

L Green

Aesthetic Dermatology Center, Rockville, MD

E Lain

SANIVA Dermatology, Pflugerville,TX

Keywords

Rosacea, Papulopustular, Benzoyl Peroxide, Efficacy, Safety

Abstract

Abstract not available.

References

1. Erlich M, Arie T, Koifman N, Talmon Y. Structure elucidation of silica-based core-shell microencapsulated drugs for topical applications by cryogenics canning electronmicroscopy. J Colloid Interface Sci. 2020;579: 778-785.

2. Bhatia N, Werschler W, Sugarman J, SteinGold L. Efficacy and safety of microencapsulated benzoyl peroxide cream, 5% in papulopustular rosacea: Results from two phase 3, vehicle-controlled trials. 2020. In Submission.

Poster PDF

Published

Jan 1, 2021

DOI https://doi.org/10.25251/skin.5.supp.25

How to Cite

Bhatia, N., Werschler, W., Baldwin, H., Sugarman, J., Stein Gold, L., Green, L., & Lain, E. (2021). Long-Term Efficacy and Safety of Benzoyl Peroxide Cream, 5%, Prepared with Microencapsulation in Papulopustular Rosacea: Results from an Extension of Two Phase 3, Vehicle-Controlled Trials. SKIN The Journal of Cutaneous Medicine, 5(1), s25. https://doi.org/10.25251/skin.5.supp.25

Issue

Vol. 5 No. 1 (2021): January Issue & Poster Presentations (WC21 Dermatology Conference®)

Section

Acne & Rosacea

This work is licensed under a Creative Commons Attribution 4.0 International License.

All authors retain copyright in their articles. All articles published open access allowing for immediate free access to the work and permitting any user to read, download, copy, distribute, print, search, or link to the full texts of articles, crawl them for indexing, pass them as data to software or use them for any other lawful purpose. Permitted reuse is defined by the following user license:

Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation.

Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.ca/ojs/.

Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.

Most read articles by the same author(s)

J Sugarman, H Baldwin, N Bhatia, Efficacy of Microencapsulated Benzoyl Peroxide (E-Bpo) Cream, 5% in Elderly Rosacea Patients , SKIN The Journal of Cutaneous Medicine: Vol. 5 No. 1 (2021): January Issue & Poster Presentations (WC21 Dermatology Conference®)
L Green, A Armstrong, CF Teller, S Bell, T Lin, Treatment of Psoriasis: A Survey on Patient Preference and Satisfaction , SKIN The Journal of Cutaneous Medicine: Vol. 4 No. 1 (2020): January Issue & Poster Presentations (2020 Winter Clinical Dermatology Conference®)
L Stein Gold, J Del Rosso, Microencapsulated Benzoyl Peroxide 3%, Microencapsulated Tretinoin 0.1% Cream: Efficacy for Pediatric and Adolescent Patients , SKIN The Journal of Cutaneous Medicine: Vol. 5 No. 1 (2021): January Issue & Poster Presentations (WC21 Dermatology Conference®)
A Moore, L Green, S Bruce, N Sadick, E Tschen, P Werschler, S Dhawan, D Forsha, M Gold, S Guenthner, S Kempers, L Kircik, J Parish, M Rendon, P Rich, L Stein-Gold, S Tyring, R Weiss, A Nasir, C Schmitz, T Boodhoo, A Kaoukhov, D Berk, F Cook-Bolden, Ayman Grada, Once-Daily Oral Sarecycline 1.5 mg/kg/day is Effective for Moderate to Severe Acne Vulgaris: Results from Two 12-Week, Phase 3, Randomized, Double-blind Clinical Trials , SKIN The Journal of Cutaneous Medicine: Vol. 4 No. 1 (2020): January Issue & Poster Presentations (2020 Winter Clinical Dermatology Conference®)
Z Draelos, F Cook-Bolden, L Green, E Guenin, G Martin, R Pillai, Comparison of a Novel Tazarotene 0.045% Lotion to Tazarotene 0.1% Cream: Patient-Reported Outcomes from a Phase 2 Clinical Trial , SKIN The Journal of Cutaneous Medicine: Vol. 4 No. 1 (2020): January Issue & Poster Presentations (2020 Winter Clinical Dermatology Conference®)
L Eichenfield, L Stein Gold, N Silverberg, T Raoof, D Hooper, A Moore, M Zaiac, T Sullivan, L Kircik, E Lain, S Dhawan, T Jones, J Weiss, Z Draelos, H Ellman, T deVries, J Jankicevic, I Stuart, Clinical Safety and Pharmacokinetics of FMX101 4% Topical Minocycline Foam in Pediatric Patients for the Treatment of Moderate-to-Severe Acne Vulgaris , SKIN The Journal of Cutaneous Medicine: Vol. 3 (2019): Supplemental Issue: Scientific Posters Presented at 2019 Fall Clinical Dermatology Conference®-Las Vegas
A Armstrong, RG Langley, KB Gordon, RB Warren, D Thaçi, L Stein Gold, L Peterson, C Madden, N Nunez Gomez, D de Cuyper, A Costanzo, Bimekizumab infection rates in patients with moderate to severe plaque psoriasis: Analysis of pooled data from 2 years of treatment in phase 3 and 3b clinical trials , SKIN The Journal of Cutaneous Medicine: Vol. 6 No. 6 (2022): November Issue & Poster Presentations from FC22 Dermatology Conference®
N Bhatia, M Ahmadyar, H Hansra, J Del Rosso, H Baldwin, AM Daniels, Early Onset of Efficacy Using a 1% and 2% Topical Minocycline Gel for the Treatment of Rosacea: a Small Open Label Study , SKIN The Journal of Cutaneous Medicine: Vol. 2 (2018): Supplemental Issue: Scientific Posters Presented at 2018 Winter Clinical Dermatology Conference®-Hawaii
H Baldwin, L Green, L Kircik, E Guenin, Efficacy and Safety of a Novel Tazarotene 0.045% Lotion in Females and Males with Moderate-to-Severe Acne , SKIN The Journal of Cutaneous Medicine: Vol. 4 No. 1 (2020): January Issue & Poster Presentations (2020 Winter Clinical Dermatology Conference®)
MG Lebwohl, J Sugarman, DM Pariser, J Bagel, T Lin, R Israel, Safety and Tolerability of Fixed Combination Halobetasol Propionate 0.01% And Tazarotene 0.045% (HP/TAZ) Lotion in Patients With Moderate-to-Severe Plaque Psoriasis: Results From a 1-Year, Open-Label Study , SKIN The Journal of Cutaneous Medicine: Vol. 4 No. 1 (2020): January Issue & Poster Presentations (2020 Winter Clinical Dermatology Conference®)

1 2 > >>

Main Article Content

Keywords

Abstract

References

Article Sidebar

Article Details

Most read articles by the same author(s)